Guided Therapeutics, Inc. (GTHP)
OTCMKTS · Delayed Price · Currency is USD
0.3000
0.00 (0.00%)
Jul 31, 2026, 2:04 PM EST
Guided Therapeutics Market Cap
Guided Therapeutics has a market cap or net worth of $28.96 million as of July 31, 2026. Its market cap has increased by 44.29% in one year.
Market Cap
28.96M
Enterprise Value
32.09M
Revenue
767.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.30
ChartMarket Cap Chart
Since July 1, 1997, Guided Therapeutics's market cap has decreased from 448.72M to 28.96M, a decrease of -93.55%. That is a compound annual growth rate of -8.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 28.96M | -37.75% |
| Dec 31, 2025 | 46.52M | 376.20% |
| Dec 31, 2024 | 9.77M | 17.63% |
| Dec 29, 2023 | 8.31M | -43.03% |
| Dec 30, 2022 | 14.58M | 84.30% |
| Dec 31, 2021 | 7.91M | 101.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RetinalGenix Technologies | 75.02M |
| Positron | 52.59M |
| Tian'an Technology Group | 45.52M |
| Vivos | 28.77M |
| Family Office of America | 27.32M |
| PetVivo Holdings | 24.15M |
| CS Diagnostics | 17.50M |
| CYduct Diagnostics | 14.15M |